Translational Insights into Peroxisome Proliferator-Activated Receptors in Experimental Acute Pancreatitis

Pancreas

Volumn 45, Issue 2, 2016, Pages 167-178

  Huang, Wei ^a,b   Szatmary, Peter ^b,c   Wan, Meihua ^a   Bharucha, Shameena ^b   Awais, Muhammad ^b   Tang, Wenfu ^a   Criddle, David N ^c   Xia, Qing ^a   Sutton, Robert ^b  

^a SICHUAN UNIVERSITY   (China)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

acute pancreatitis; inflammation; metabolic disorders; peroxisome proliferator activated receptors; transcription factors

Indexed keywords

ARGININE; BILE ACID; CERULETIDE; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE; STAT PROTEIN; TAUROCHOLIC ACID; TRANSCRIPTION FACTOR; TROGLITAZONE; LIGAND;

ACINAR CELL; ACUTE PANCREATITIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME ACTIVATION; EXPERIMENTAL PANCREATITIS; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RNA TRANSLATION; ACUTE DISEASE; AGONISTS; ANIMAL; DRUG THERAPY; FORECASTING; METABOLISM; PANCREATITIS; PROCEDURES; TRANSLATIONAL RESEARCH; TRENDS;

ACUTE DISEASE; ANIMALS; DRUG THERAPY; FORECASTING; HUMANS; LIGANDS; PANCREATITIS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; TRANSCRIPTION FACTORS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84955705877     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000472     Document Type: Review

References (145)

1. Pandol SJ, Saluja AK, Imrie CW, Acute pancreatitis: bench to the bedside. Gastroenterology. 2007; 132: 1127-1151.
2. Das SL, Singh PP, Phillips AR, Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis. Gut. 2014; 63: 818-831.
3. Sawalhi S, Al-Maramhy H, Abdelrahman AI, Does the presence of obesity and/or metabolic syndrome affect the course of acute pancreatitis?: a prospective study. Pancreas. 2014; 43: 565-570.
4. Peery AF, Dellon ES, Lund J, Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012; 143: 1179-1187. e1-3.
5. Yadav D, Lowenfels AB,. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013; 144: 1252-1261.
6. Tenner S, Baillie J, DeWitt J, American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013; 108: 1400-15; 1416.
7. Petrov MS, Shanbhag S, Chakraborty M, Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology. 2010; 139: 813-820.
8. Tsuang W, Navaneethan U, Ruiz L, Hypertriglyceridemic pancreatitis: presentation and management. Am J Gastroenterol. 2009; 104: 984-991.
9. Saligram S, Lo D, Saul M, Analyses of hospital administrative data that use diagnosis codes overestimate the cases of acute pancreatitis. Clin Gastroenterol Hepatol. 2012; 10: 805.e1-811.e1.
10. Lindkvist B, Appelros S, Regner S, A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose. Pancreatology. 2012; 12: 317-324.
11. Bessembinders K, Wielders J, van de Wiel A,. Severe hypertriglyceridemia influenced by alcohol (SHIBA). Alcohol Alcohol. 2011; 46: 113-116.
12. Van de Wiel A,. The effect of alcohol on postprandial and fasting triglycerides. Int J Vasc Med. 2012; 2012: 862504.
13. Samad A, James A, Wong J, Insulin protects pancreatic acinar cells from palmitoleic acid-induced cellular injury. J Biol Chem. 2014; 289: 23582-23595.
14. Hegyi P, Rakonczay Z Jr, Sari R, Insulin is necessary for the hypertrophic effect of cholecystokinin-octapeptide following acute necrotizing experimental pancreatitis. World J Gastroenterol. 2004; 10: 2275-2277.
15. Du JD, Zheng X, Huang ZQ, Effects of intensive insulin therapy combined with low molecular weight heparin anticoagulant therapy on severe pancreatitis. Exp Ther Med. 2014; 8: 141-146.
16. Johnson CD, Abu-Hilal M,. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut. 2004; 53: 1340-1344.
17. Guo Q, Li A, Xia Q, The role of organ failure and infection in necrotizing pancreatitis: a prospective study. Ann Surg. 2014; 259: 1201-1207.
18. Venteclef N, Jakobsson T, Steffensen KR, Metabolic nuclear receptor signaling and the inflammatory acute phase response. Trends Endocrinol Metab. 2011; 22: 333-343.
19. Whitehead JP,. Diabetes: new conductors for the peroxisome proliferator-activated receptor γ (PPARγ) orchestra. Int J Biochem Cell Biol. 2011; 43: 1071-1074.
20. Azhar S,. Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease. Future Cardiol. 2010; 6: 657-691.
21. Monsalve FA, Pyarasani RD, Delgado-Lopez F, Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases. Mediators Inflamm. 2013; 2013: 549627.
22. Fuentes E, Guzman-Jofre L, Moore-Carrasco R, Role of PPARs in inflammatory processes associated with metabolic syndrome (Review). Mol Med Rep. 2013; 8: 1611-1616.
23. Menendez-Gutierrez MP, Roszer T, Ricote M,. Biology and therapeutic applications of peroxisome proliferator-activated receptors. Curr Top Med Chem. 2012; 12: 548-584.
24. Varga T, Czimmerer Z, Nagy L,. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta. 1812; 2011: 1007-1022.
25. Standage SW, Caldwell CC, Zingarelli B, Reduced peroxisome proliferator-activated receptor α expression is associated with decreased survival and increased tissue bacterial load in sepsis. Shock. 2012; 37: 164-169.
26. Boggild AK, Krudsood S, Patel SN, Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2009; 49: 841-849.
27. Schmidt MV, Brune B, von Knethen A,. The nuclear hormone receptor PPARγ as a therapeutic target in major diseases. ScientificWorldJournal. 2010; 10: 2181-2197.
28. Chandra V, Huang P, Hamuro Y, Structure of the intact PPAR-gamma-RXR-nuclear receptor complex on DNA. Nature. 2008; 456: 350-356.
29. Daynes RA, Jones DC,. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol. 2002; 2: 748-759.
30. Poulsen L, Siersbaek M, Mandrup S,. PPARs: fatty acid sensors controlling metabolism. Semin Cell Dev Biol. 2012; 23: 631-639.
31. Ahmadian M, Suh JM, Hah N, PPARγ signaling and metabolism: the good, the bad and the future. Nat Med. 2013; 19: 557-566.
32. Ricote M, Glass CK,. PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta. 1771; 2007: 926-935.
33. Schupp M, Lazar MA,. Endogenous ligands for nuclear receptors: digging deeper. J Biol Chem. 2010; 285: 40409-40415.
34. Gray KD, Simovic MO, Chapman WC, Systemic NF-kappaB activation in a transgenic mouse model of acute pancreatitis. J Surg Res. 2003; 110: 310-314.
35. Aleksic T, Baumann B, Wagner M, Cellular immune reaction in the pancreas is induced by constitutively active IkappaB kinase-2. Gut. 2007; 56: 227-236.
36. Baumann B, Wagner M, Aleksic T, Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. J Clin Invest. 2007; 117: 1502-1513.
37. Algul H, Treiber M, Lesina M, Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis. J Clin Invest. 2007; 117: 1490-1501.
38. Huang H, Liu Y, Daniluk J, Activation of nuclear factor-κB in acinar cells increases the severity of pancreatitis in mice. Gastroenterology. 2013; 144: 202-210.
39. Neuhofer P, Liang S, Einwachter H, Deletion of IκBα activates RelA to reduce acute pancreatitis in mice through up-regulation of Spi2A. Gastroenterology. 2013; 144: 192-201.
40. Gukovsky I, Gukovskaya A,. Nuclear factor-κB in pancreatitis: jack-of-all-trades, but which one is more important? Gastroenterology. 2013; 144: 26-29.
41. Eferl R, Wagner EF,. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003; 3: 859-868.
42. Criddle DN, McLaughlin E, Murphy JA, The pancreas misled: signals to pancreatitis. Pancreatology. 2007; 7: 436-446.
43. Gulcubuk A, Haktanir D, Cakiris A, Effects of curcumin on proinflammatory cytokines and tissue injury in the early and late phases of experimental acute pancreatitis. Pancreatology. 2013; 13: 347-354.
44. Samuel I, Yuan Z, Meyerholz DK, A novel model of severe gallstone pancreatitis: murine pancreatic duct ligation results in systemic inflammation and substantial mortality. Pancreatology. 2010; 10: 536-544.
45. Ferrara C, Gress TM, Mueller-Pillasch F, Expression of the protooncogene jun is induced in the rat pancreas by cerulein infusion. Pancreas. 1997; 15: 160-167.
46. Fu K, Sarras MP Jr, De Lisle RC, Expression of oxidative stress-responsive genes and cytokine genes during caerulein-induced acute pancreatitis. Am J Physiol. 1997; 273: G696-G705.
47. Fu K, Tomita T, Sarras MP Jr, Metallothionein protects against cerulein-induced acute pancreatitis: analysis using transgenic mice. Pancreas. 1998; 17: 238-246.
48. Simovic MO, Ballard BR, Gray KD, The STAT4 and STAT6 pathways in pancreatitis-associated lung injury. J Surg Res. 2007; 137: 10-15.
49. Chao KC, Chao KF, Chuang CC, Blockade of interleukin 6 accelerates acinar cell apoptosis and attenuates experimental acute pancreatitis in vivo. Br J Surg. 2006; 93: 332-338.
50. Ramnath RD, Sun J, Bhatia M,. Involvement of SRC family kinases in substance P-induced chemokine production in mouse pancreatic acinar cells and its significance in acute pancreatitis. J Pharmacol Exp Ther. 2009; 329: 418-428.
51. Yubero S, Ramudo L, Manso MA, Mechanisms of dexamethasone-mediated chemokine down-regulation in mild and severe acute pancreatitis. Biochim Biophys Acta. 1792; 2009: 1205-1211.
52. Chen P, Huang L, Sun Y, Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury. Cytokine. 2011; 54: 305-314.
53. Chen P, Huang L, Zhang Y, The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity. Int J Mol Med. 2011; 27: 731-738.
54. Ju KD, Lim JW, Kim KH, Potential role of NADPH oxidase-mediated activation of Jak2/Stat3 and mitogen-activated protein kinases and expression of TGF-β1 in the pathophysiology of acute pancreatitis. Inflamm Res. 2011; 60: 791-800.
55. Awla D, Zetterqvist AV, Abdulla A, NFATc3 regulates trypsinogen activation, neutrophil recruitment, and tissue damage in acute pancreatitis in mice. Gastroenterology. 2012; 143: 1352-1360.e1-7.
56. Muili KA, Wang D, Orabi AI, Bile acids induce pancreatic acinar cell injury and pancreatitis by activating calcineurin. J Biol Chem. 2013; 288: 570-580.
57. Hoque R, Malik AF, Gorelick F, Sterile inflammatory response in acute pancreatitis. Pancreas. 2012; 41: 353-357.
58. Gu H, Werner J, Bergmann F, Necro-inflammatory response of pancreatic acinar cells in the pathogenesis of acute alcoholic pancreatitis. Cell Death Dis. 2013; 4: e816.
59. Hoque R, Sohail M, Malik A, TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis. Gastroenterology. 2011; 141: 358-369.
60. Masamune A, Satoh K, Sakai Y, Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. Pancreas. 2002; 24: 130-138.
61. Malleo G, Mazzon E, Siriwardena AK, Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence. Shock. 2007; 28: 130-140.
62. Vona-Davis L, Yu A, Magabo K, Peptide YY attenuates transcription factor activity in tumor necrosis factor-alpha-induced pancreatitis. J Am Coll Surg. 2004; 199: 87-95.
63. Yu JH, Kim KH, Kim H,. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas. Int J Biochem Cell Biol. 2008; 40: 677-688.
64. Calvo EL, Mallo GV, Fiedler F, Clusterin overexpression in rat pancreas during the acute phase of pancreatitis and pancreatic development. Eur J Biochem. 1998; 254: 282-289.
65. Ortiz EM, Dusetti NJ, Vasseur S, The pancreatitis-associated protein is induced by free radicals in AR4-2 J cells and confers cell resistance to apoptosis. Gastroenterology. 1998; 114: 808-816.
66. Wan H, Yuan Y, Qian A, Pioglitazone, a PPARgamma ligand, suppresses NFkappaB activation through inhibition of IkappaB kinase activation in cerulein-treated AR42J cells. Biomed Pharmacother. 2008; 62: 466-472.
67. Criddle DN, Gerasimenko JV, Baumgartner HK, Calcium signalling and pancreatic cell death: apoptosis or necrosis? Cell Death Differ. 2007; 14: 1285-1294.
68. Booth DM, Murphy JA, Mukherjee R, Reactive oxygen species induced by bile acid induce apoptosis and protect against necrosis in pancreatic acinar cells. Gastroenterology. 2011; 140: 2116-2125.
69. Kaiser AM, Saluja AK, Sengupta A, Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis. Am J Physiol. 1995; 269: C1295-C1304.
70. Sung KF, Odinokova IV, Mareninova OA, Prosurvival Bcl-2 proteins stabilize pancreatic mitochondria and protect against necrosis in experimental pancreatitis. Exp Cell Res. 2009; 315: 1975-1989.
71. Bernard C,. Lecons de Physiologie Experimentale. Paris, France: Bailliere; 1856; Vol 2: 278.
72. Genovese T, Mazzon E, Di Paola R, Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein. Immunology. 2006; 118: 559-570.
73. Griesbacher T, Pommer V, Schuligoi R, Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis. Int Immunopharmacol. 2008; 8: 325-329.
74. Ding JL, Zhou ZG, Zhou XY, Attenuation of acute pancreatitis by peroxisome proliferator-activated receptor-α in rats: the effect on Toll-like receptor signaling pathways. Pancreas. 2013; 42: 114-122.
75. Paterniti I, Mazzon E, Riccardi L, Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein-and taurocholate-induced acute pancreatitis in mice. Surgery. 2012; 152: 90-106.
76. Wan MH, Huang W, Latawiec D, Review of experimental animal models of biliary acute pancreatitis and recent advances in basic research. HPB (Oxford). 2012; 14: 73-81.
77. Voronina S, Longbottom R, Sutton R, Bile acids induce calcium signals in mouse pancreatic acinar cells: implications for bile-induced pancreatic pathology. J Physiol. 2002; 540: 49-55.
78. Perides G, Laukkarinen JM, Vassileva G, Biliary acute pancreatitis in mice is mediated by the G-protein-coupled cell surface bile acid receptor Gpbar1. Gastroenterology. 2010; 138: 715-725.
79. Xu P, Zhou XJ, Chen LQ, Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis. World J Gastroenterol. 2007; 13: 1983-1988.
80. Gutierrez PT, Folch-Puy E, Bulbena O, Oxidised lipids present in ascitic fluid interfere with the regulation of the macrophages during acute pancreatitis, promoting an exacerbation of the inflammatory response. Gut. 2008; 57: 642-648.
81. Celiński K, Madro A, Prozorow-Krol B, Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis. Med Sci Monit. 2009; 15: BR21-BR29.
82. Chen C, Xu S, Wang WX, Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury. Arch Med Res. 2009; 40: 79-88.
83. Xu P, Xu K, Wang J, Pioglitazone: a promising therapeutic tool in sodium taurocholate-induced severe acute pancreatitis. Dig Dis Sci. 2011; 56: 1082-1089.
84. Xu P, Lou XL, Chen C, Effects of peroxisome proliferator-activated receptor-γ activation on apoptosis in rats with acute pancreatitis. Dig Dis Sci. 2013; 58: 3516-3523.
85. He ZJ, Winston JH, Yusuf TE, Intraductal administration of an NK1 receptor antagonist attenuates the inflammatory response to retrograde infusion of radiological contrast in rats: implications for the pathogenesis and prevention of ERCP-induced pancreatitis. Pancreas. 2003; 27: e13-e17.
86. Folch-Puy E, Granell S, Iovanna JL, Peroxisome proliferator-activated receptor gamma agonist reduces the severity of post-ERCP pancreatitis in rats. World J Gastroenterol. 2006; 12: 6458-6463.
87. Murphy JA, Criddle DN, Sherwood M, Direct activation of cytosolic Ca2+ signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells. Gastroenterology. 2008; 135: 632-641.
88. Criddle DN, Booth DM, Mukherjee R, Cholecystokinin-58 and cholecystokinin-8 exhibit similar actions on calcium signaling, zymogen secretion, and cell fate in murine pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol. 2009; 297: G1085-G1092.
89. Lerch MM, Gorelick FS,. Models of acute and chronic pancreatitis. Gastroenterology. 2013; 144: 1180-1193.
90. Bieger W, Seybold J, Kern HF,. Studies on intracellular transport of secretory proteins in the rat exocrine pancreas. V. Kinetic studies on accelerated transport following caerulein infusion in vivo. Cell Tissue Res. 1976; 170: 203-219.
91. Onur OE, Guneysel O, Akoglu H, Adrenomedullin reduces the severity of cerulein-induced acute pancreatitis. Peptides. 2007; 28: 2179-2183.
92. Esrefoglu M, Gul M, Ates B, Ultrastructural clues for the protective effect of ascorbic acid and N-acetylcysteine against oxidative damage on caerulein-induced pancreatitis. Pancreatology. 2006; 6: 477-485.
93. Ethridge RT, Hashimoto K, Chung DH, Selective inhibition of NF-kappaB attenuates the severity of cerulein-induced acute pancreatitis. J Am Coll Surg. 2002; 195: 497-505.
94. Frossard JL, Saluja AK, Mach N, In vivo evidence for the role of GM-CSF as a mediator in acute pancreatitis-associated lung injury. Am J Physiol Lung Cell Mol Physiol. 2002; 283: L541-L548.
95. Kimura K, Tominaga K, Fujii M, Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate. Arzneimittelforschung. 1998; 48: 65-69.
96. Selig L, Sack U, Gaiser S, Characterisation of a transgenic mouse expressing R122H human cationic trypsinogen. BMC Gastroenterol. 2006; 6: 30.
97. Malleo G, Mazzon E, Genovese T, Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis. Shock. 2008; 29: 89-97.
98. Slogoff MI, Ethridge RT, Rajaraman S, COX-2 inhibition results in alterations in nuclear factor (NF)-kappaB activation but not cytokine production in acute pancreatitis. J Gastrointest Surg. 2004; 8: 511-519.
99. Lau HY, Bhatia M,. Effect of CP-96,345 on the expression of adhesion molecules in acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol. 2007; 292: G1283-G1292.
100. Minutoli L, Altavilla D, Marini H, Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis. Life Sci. 2004; 75: 2853-2866.
101. Rifai Y, Elder AS, Carati CJ, The tripeptide analog feG ameliorates severity of acute pancreatitis in a caerulein mouse model. Am J Physiol Gastrointest Liver Physiol. 2008; 294: G1094-G1099.
102. 2 attenuates the severity of cerulein-induced acute pancreatitis. Pancreas. 2003; 27: 58-66.
103. Cuzzocrea S, Pisano B, Dugo L, Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein. Intensive Care Med. 2004; 30: 951-956.
104. Konturek PC, Dembinski A, Warzecha Z, Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, protects pancreas against acute cerulein-induced pancreatitis. World J Gastroenterol. 2005; 11: 6322-6329.
105. Rollins MD, Sudarshan S, Firpo MA, Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. J Gastrointest Surg. 2006; 10: 1120-1130.
106. Ivashchenko CY, Duan SZ, Usher MG, PPAR-gamma knockout in pancreatic epithelial cells abolishes the inhibitory effect of rosiglitazone on caerulein-induced acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2007; 293: G319-G326.
107. Wan H, Yuan Y, Liu J, Pioglitazone, a PPAR-γ activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor. Transl Res. 2012; 160: 153-161.
108. Yu WG, Xu G, Ren GJ, Preventive action of curcumin in experimental acute pancreatitis in mouse. Indian J Med Res. 2011; 134: 717-724.
109. Dawra R, Sharif R, Phillips P, Development of a new mouse model of acute pancreatitis induced by administration of l-arginine. Am J Physiol Gastrointest Liver Physiol. 2007; 292: G1009-G1018.
110. Weaver C, Bishop AE, Polak JM,. Pancreatic changes elicited by chronic administration of excess l-arginine. Exp Mol Pathol. 1994; 60: 71-87.
111. Sidhu S, Pandhi P, Malhotra S, Rosiglitazone promotes pancreatic regeneration in experimental model of acute pancreatitis. Fundam Clin Pharmacol. 2011; 25: 237-247.
112. Hong S, Qiwen B, Ying J, Body mass index and the risk and prognosis of acute pancreatitis: a meta-analysis. Eur J Gastroenterol Hepatol. 2011; 23: 1136-1143.
113. Wang SQ, Li SJ, Feng QX, Overweight is an additional prognostic factor in acute pancreatitis: a meta-analysis. Pancreatology. 2011; 11: 92-98.
114. Chen SM, Xiong GS, Wu SM,. Is obesity an indicator of complications and mortality in acute pancreatitis? An updated meta-analysis. J Dig Dis. 2012; 13: 244-251.
115. Tukiainen E, Kylanpaa ML, Ebeling P, Leptin and adiponectin levels in acute pancreatitis. Pancreas. 2006; 32: 211-214.
116. Schaffler A, Landfried K, Volk M, Potential of adipocytokines in predicting peripancreatic necrosis and severity in acute pancreatitis: pilot study. J Gastroenterol Hepatol. 2007; 22: 326-334.
117. Segersvard R, Sylvan M, Herrington M, Obesity increases the severity of acute experimental pancreatitis in the rat. Scand J Gastroenterol. 2001; 36: 658-663.
118. Segersvard R, Sylvan M, Lempinen M, Impact of chronic and acute high-fat feeding on acute experimental pancreatitis complicated by endotoxinaemia. Scand J Gastroenterol. 2004; 39: 74-80.
119. Araki H, Nishihara T, Matsuda M, Adiponectin plays a protective role in caerulein-induced acute pancreatitis in mice fed a high-fat diet. Gut. 2008; 57: 1431-1440.
120. Nishihara T, Baba M, Matsuda M, Adiponectin deficiency enhances colorectal carcinogenesis and liver tumor formation induced by azoxymethane in mice. World J Gastroenterol. 2008; 14: 6473-6480.
121. Wang Y, Sternfeld L, Yang F, Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells. Gut. 2009; 58: 422-430.
122. Pini M, Rhodes DH, Castellanos KJ, Rosiglitazone improves survival and hastens recovery from pancreatic inflammation in obese mice. PLoS One. 2012; 7: e40944.
123. Niyaz B, Zhao KL, Liu LM, Rosiglitazone attenuates the severity of hyperlipidemic severe acute pancreatitis in rats. Exp Ther Med. 2013; 6: 989-994.
124. Malecki EA, Castellanos KJ, Cabay RJ, Therapeutic administration of orlistat, rosiglitazone, or the chemokine receptor antagonist RS102895 fails to improve the severity of acute pancreatitis in obese mice. Pancreas. 2014; 43: 903-908.
125. Cuzzocrea S, Mazzon E, Di Paola R, The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation. J Leukoc Biol. 2006; 79: 999-1010.
126. Di Paola R, Esposito E, Mazzon E, Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan. Shock. 2006; 26: 477-484.
127. Petersen O,. Can specific calcium channel blockade be the basis for a drug-based treatment of acute pancreatitis? Expert Rev Gastroenterol Hepatol. 2014; 8: 339-341.
128. Mayerle J,. A novel role for leucocytes in determining the severity of acute pancreatitis. Gut. 2009; 58: 1440-1441.
129. Reddy RC, Narala VR, Keshamouni VG, Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}. Blood. 2008; 112: 4250-4258.
130. Ferreira AE, Sisti F, Sonego F, PPAR-γ/IL-10 axis inhibits MyD88 expression and ameliorates murine polymicrobial sepsis. J Immunol. 2014; 192: 2357-2365.
131. Schmidt MV, Paulus P, Kuhn AM, Peroxisome proliferator-activated receptor γ-induced T cell apoptosis reduces survival during polymicrobial sepsis. Am J Respir Crit Care Med. 2011; 184: 64-74.
132. Mandard S, Zandbergen F, Tan NS, The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem. 2004; 279: 34411-34420.
133. Nair S, Yadav D, Pitchumoni CS,. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol. 2000; 95: 2795-2800.
134. Petrov MS, Zagainov VE,. Influence of enteral versus parenteral nutrition on blood glucose control in acute pancreatitis: a systematic review. Clin Nutr. 2007; 26: 514-523.
135. Mounzer R, Langmead CJ, Wu BU, Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology. 2012; 142: 1476-1482; quiz e15-6.
136. Svensson JO,. Role of intravenously infused insulin in treatment of acute pancreatitis. A double-blind study. Scand J Gastroenterol. 1975; 10: 487-490.
137. Hallberg D,. Acute pancreatitis treated with and without addition of insulin. Acta Chir Scand. 1977; 143: 451-456.
138. Mankad P, James A, Siriwardena AK, Insulin protects pancreatic acinar cells from cytosolic calcium overload and inhibition of plasma membrane calcium pump. J Biol Chem. 2012; 287: 1823-1836.
139. Criddle DN, Raraty MG, Neoptolemos JP, Ethanol toxicity in pancreatic acinar cells: mediation by nonoxidative fatty acid metabolites. Proc Natl Acad Sci USA. 2004; 101: 10738-10743.
140. Criddle DN, Murphy J, Fistetto G, Fatty acid ethyl esters cause pancreatic calcium toxicity via inositol trisphosphate receptors and loss of ATP synthesis. Gastroenterology. 2006; 130: 781-793.
141. Sand J, Nordback I,. Acute pancreatitis: risk of recurrence and late consequences of the disease. Nat Rev Gastroenterol Hepatol. 2009; 6: 470-477.
142. Pelli H, Lappalainen-Lehto R, Piironen A, Risk factors for recurrent acute alcohol-associated pancreatitis: a prospective analysis. Scand J Gastroenterol. 2008; 43: 614-621.
143. Nikkola J, Raty S, Laukkarinen J, Abstinence after first acute alcohol-associated pancreatitis protects against recurrent pancreatitis and minimizes the risk of pancreatic dysfunction. Alcohol Alcohol. 2013; 48: 483-486.
144. Fortunato F, Berger I, Gross ML, Immune-compromised state in the rat pancreas after chronic alcohol exposure: the role of peroxisome proliferator-activated receptor gamma. J Pathol. 2007; 213: 441-452.
145. Kung J, Henry RR,. Thiazolidinedione safety. Expert Opin Drug Saf. 2012; 11: 565-579.